当前大麻使用与成人舒张功能障碍指数增加有关:回顾性分析

IF 5.9 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Rahul Almeida B.S. Candidate in Biology , Yigit Unlu (Co-first author), M.D. , Mina Navabzadeh PharmD. , Jing Cheng M.D., MS, Ph.D. , Lam Tran B.A. , Matthew Springer Ph.D. , Leila Mohammadi M.D., Ph.D.
{"title":"当前大麻使用与成人舒张功能障碍指数增加有关:回顾性分析","authors":"Rahul Almeida B.S. Candidate in Biology ,&nbsp;Yigit Unlu (Co-first author), M.D. ,&nbsp;Mina Navabzadeh PharmD. ,&nbsp;Jing Cheng M.D., MS, Ph.D. ,&nbsp;Lam Tran B.A. ,&nbsp;Matthew Springer Ph.D. ,&nbsp;Leila Mohammadi M.D., Ph.D.","doi":"10.1016/j.ajpc.2025.101175","DOIUrl":null,"url":null,"abstract":"<div><h3>Therapeutic Area</h3><div>ASCVD/CVD Risk Factors</div></div><div><h3>Background</h3><div>Although the effects of tobacco use on cardiac function are well documented, less is known about cannabis use and its impact on systolic and diastolic function parameters as measured by echocardiography. In a retrospective study, we evaluated the relationship between cannabis use and cardiac functional parameters (systolic and diastolic) that have predictive value in future heart failure (HF) related morbidity and mortality.</div></div><div><h3>Methods</h3><div>We screened patients who underwent echocardiography imaging at UCSF Medical Center between March 2018 and May 2024 who also had questionnaire data available for cannabis use (smoking and edibles; n=189 [101 F, 88 M], mean±SD for age: 65.9±11.7). Cardiac function parameters considered were both systolic (left ventricular ejection fraction (LVEF)) and diastolic (left atrial volume index (LAVI), left ventricular end diastolic volume index (LVEDVI), and left ventricular internal diameter in diastole (LVIDd)). Categorical differences in cardiac function parameters between users (n=87), non-users (n=60), and prior users (n=42) were quantified in a generalized linear model and expressed as beta coefficient (ß) ± SEM after adjustments for age, sex, and brain natriuretic peptide (BNP). p&lt;0.05 was considered significant.</div></div><div><h3>Results</h3><div>Cannabis use was associated with a higher LVEDVI (ß=12.9±4.7, p=0.007) and LVIDd (ß=0.47±0.19, p=0.01) compared to non-users. Cannabis use was not a significant determinant of LVEF or LAVI (both p&gt;0.05). However, there was a trend of an association between cannabis use and a higher LAVI score in women (ß=22.1±11.4, p=0.06) that was not observed in men (p=0.28). Similar results were obtained when the analysis was adjusted for patient age, sex, BNP, tobacco use status, and LVEF (for diastolic function parameters). Prior use (those that have reported to have ever used cannabis) was not a significant determinant of any of the measures of systolic or diastolic function.</div></div><div><h3>Conclusions</h3><div>Current cannabis use is associated with higher LVEDVI and LVIDd, and not with differences in LVEF. Cannabis use is not associated with LAVI score in men, but our results are suggestive of a potential association in women. Our findings point to a relationship between cannabis use and subclinical cardiac alterations that can inform preventive cardiovascular interventions for at-risk populations.</div></div>","PeriodicalId":72173,"journal":{"name":"American journal of preventive cardiology","volume":"23 ","pages":"Article 101175"},"PeriodicalIF":5.9000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CURRENT CANNABIS USE IS ASSOCIATED WITH INCREASED INDEXES OF DIASTOLIC DYSFUNCTION IN ADULTS: A RETROSPECTIVE ANALYSIS\",\"authors\":\"Rahul Almeida B.S. Candidate in Biology ,&nbsp;Yigit Unlu (Co-first author), M.D. ,&nbsp;Mina Navabzadeh PharmD. ,&nbsp;Jing Cheng M.D., MS, Ph.D. ,&nbsp;Lam Tran B.A. ,&nbsp;Matthew Springer Ph.D. ,&nbsp;Leila Mohammadi M.D., Ph.D.\",\"doi\":\"10.1016/j.ajpc.2025.101175\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Therapeutic Area</h3><div>ASCVD/CVD Risk Factors</div></div><div><h3>Background</h3><div>Although the effects of tobacco use on cardiac function are well documented, less is known about cannabis use and its impact on systolic and diastolic function parameters as measured by echocardiography. In a retrospective study, we evaluated the relationship between cannabis use and cardiac functional parameters (systolic and diastolic) that have predictive value in future heart failure (HF) related morbidity and mortality.</div></div><div><h3>Methods</h3><div>We screened patients who underwent echocardiography imaging at UCSF Medical Center between March 2018 and May 2024 who also had questionnaire data available for cannabis use (smoking and edibles; n=189 [101 F, 88 M], mean±SD for age: 65.9±11.7). Cardiac function parameters considered were both systolic (left ventricular ejection fraction (LVEF)) and diastolic (left atrial volume index (LAVI), left ventricular end diastolic volume index (LVEDVI), and left ventricular internal diameter in diastole (LVIDd)). Categorical differences in cardiac function parameters between users (n=87), non-users (n=60), and prior users (n=42) were quantified in a generalized linear model and expressed as beta coefficient (ß) ± SEM after adjustments for age, sex, and brain natriuretic peptide (BNP). p&lt;0.05 was considered significant.</div></div><div><h3>Results</h3><div>Cannabis use was associated with a higher LVEDVI (ß=12.9±4.7, p=0.007) and LVIDd (ß=0.47±0.19, p=0.01) compared to non-users. Cannabis use was not a significant determinant of LVEF or LAVI (both p&gt;0.05). However, there was a trend of an association between cannabis use and a higher LAVI score in women (ß=22.1±11.4, p=0.06) that was not observed in men (p=0.28). Similar results were obtained when the analysis was adjusted for patient age, sex, BNP, tobacco use status, and LVEF (for diastolic function parameters). Prior use (those that have reported to have ever used cannabis) was not a significant determinant of any of the measures of systolic or diastolic function.</div></div><div><h3>Conclusions</h3><div>Current cannabis use is associated with higher LVEDVI and LVIDd, and not with differences in LVEF. Cannabis use is not associated with LAVI score in men, but our results are suggestive of a potential association in women. Our findings point to a relationship between cannabis use and subclinical cardiac alterations that can inform preventive cardiovascular interventions for at-risk populations.</div></div>\",\"PeriodicalId\":72173,\"journal\":{\"name\":\"American journal of preventive cardiology\",\"volume\":\"23 \",\"pages\":\"Article 101175\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of preventive cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666667725002508\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of preventive cardiology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666667725002508","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

治疗领域ascvd /CVD危险因素背景虽然烟草使用对心功能的影响有充分的文献记载,但对大麻使用及其对超声心动图测量的收缩和舒张功能参数的影响知之甚少。在一项回顾性研究中,我们评估了大麻使用与心脏功能参数(收缩压和舒张压)之间的关系,这些参数对未来心力衰竭(HF)相关的发病率和死亡率具有预测价值。方法筛选2018年3月至2024年5月期间在加州大学旧金山分校医学中心接受超声心动图成像的患者,这些患者也有大麻使用问卷数据(吸烟和食用;n=189 [101 F, 88 M],年龄平均±SD: 65.9±11.7)。考虑的心功能参数包括收缩期(左室射血分数(LVEF))和舒张期(左房容积指数(LAVI)、左室舒张末期容积指数(LVEDVI)和左室舒张内径(LVIDd))。使用者(n=87)、非使用者(n=60)和既往使用者(n=42)之间心功能参数的分类差异采用广义线性模型进行量化,并在调整年龄、性别和脑利钠肽(BNP)后表示为β系数(ß)±SEM。p;0.05被认为是显著的。结果与未使用扫描单抗的患者相比,使用扫描单抗的患者LVEDVI (ß=12.9±4.7,p=0.007)和LVIDd (ß=0.47±0.19,p=0.01)较高。大麻使用并不是LVEF或LAVI的显著决定因素(均为0.05)。然而,大麻使用与女性较高的LAVI评分之间存在关联趋势(ß=22.1±11.4,p=0.06),而在男性中未观察到这一趋势(p=0.28)。当对患者年龄、性别、BNP、烟草使用状况和LVEF(舒张功能参数)进行校正后,得到了类似的结果。先前使用(那些报告曾经使用大麻)不是任何收缩期或舒张期功能测量的重要决定因素。结论当前使用大麻与较高的LVEDVI和LVIDd有关,而与LVEF的差异无关。大麻使用与男性LAVI评分无关,但我们的研究结果提示了女性的潜在关联。我们的研究结果指出大麻使用与亚临床心脏改变之间的关系,可以为高危人群提供预防性心血管干预措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
CURRENT CANNABIS USE IS ASSOCIATED WITH INCREASED INDEXES OF DIASTOLIC DYSFUNCTION IN ADULTS: A RETROSPECTIVE ANALYSIS

Therapeutic Area

ASCVD/CVD Risk Factors

Background

Although the effects of tobacco use on cardiac function are well documented, less is known about cannabis use and its impact on systolic and diastolic function parameters as measured by echocardiography. In a retrospective study, we evaluated the relationship between cannabis use and cardiac functional parameters (systolic and diastolic) that have predictive value in future heart failure (HF) related morbidity and mortality.

Methods

We screened patients who underwent echocardiography imaging at UCSF Medical Center between March 2018 and May 2024 who also had questionnaire data available for cannabis use (smoking and edibles; n=189 [101 F, 88 M], mean±SD for age: 65.9±11.7). Cardiac function parameters considered were both systolic (left ventricular ejection fraction (LVEF)) and diastolic (left atrial volume index (LAVI), left ventricular end diastolic volume index (LVEDVI), and left ventricular internal diameter in diastole (LVIDd)). Categorical differences in cardiac function parameters between users (n=87), non-users (n=60), and prior users (n=42) were quantified in a generalized linear model and expressed as beta coefficient (ß) ± SEM after adjustments for age, sex, and brain natriuretic peptide (BNP). p<0.05 was considered significant.

Results

Cannabis use was associated with a higher LVEDVI (ß=12.9±4.7, p=0.007) and LVIDd (ß=0.47±0.19, p=0.01) compared to non-users. Cannabis use was not a significant determinant of LVEF or LAVI (both p>0.05). However, there was a trend of an association between cannabis use and a higher LAVI score in women (ß=22.1±11.4, p=0.06) that was not observed in men (p=0.28). Similar results were obtained when the analysis was adjusted for patient age, sex, BNP, tobacco use status, and LVEF (for diastolic function parameters). Prior use (those that have reported to have ever used cannabis) was not a significant determinant of any of the measures of systolic or diastolic function.

Conclusions

Current cannabis use is associated with higher LVEDVI and LVIDd, and not with differences in LVEF. Cannabis use is not associated with LAVI score in men, but our results are suggestive of a potential association in women. Our findings point to a relationship between cannabis use and subclinical cardiac alterations that can inform preventive cardiovascular interventions for at-risk populations.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
American journal of preventive cardiology
American journal of preventive cardiology Cardiology and Cardiovascular Medicine
CiteScore
6.60
自引率
0.00%
发文量
0
审稿时长
76 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信